AcariaHealth is proud to partner with AbbVie to bring you VYALEV™ (foscarbidopa/foslevodopa), accompanied by our compassionate support. This innovative treatment is the first and only 24-hour subcutaneous infusion of levodopa-based therapy designed specifically for managing motor fluctuations in adults with advanced Parkinson’s disease.

What Is VYALEV™?
VYALEV™ represents a significant advancement in the treatment of advanced Parkinson’s disease, offering continuous subcutaneous infusion of levodopa. Developed to overcome the limitations of oral medications as the disease progresses, VYALEV™ has been shown in clinical studies to increase "on" time—periods of optimal motor symptom control—while reducing "off" time, when symptoms resurface. This groundbreaking therapy aims to enhance the daily lives of those living with advanced Parkinson’s disease.

Understanding Parkinson’s Disease
Parkinson’s disease is a progressive neurological disorder marked by symptoms such as tremors, muscle rigidity, slowed movement, and balance issues, resulting from the loss of dopamine-producing cells in the brain. As the disease progresses, patients may experience both motor and non-motor fluctuations, along with involuntary movements, significantly impacting daily activities. While there is currently no cure, available treatments can help alleviate symptoms and improve overall quality of life.

How AcariaHealth Can Support You
At AcariaHealth, we are committed to transforming lives with compassionate care and making a meaningful difference in your journey. As a comprehensive specialty pharmacy, we offer more than just medication; we provide compassionate support every step of the way. Our goal is to ensure patients receive not only their medications but also the resources needed to manage their conditions effectively.

Want to Learn More?
For detailed prescribing information, visit vyalev.com. Explore additional resources for healthcare professionals at vyalevhcp.com.

Stay connected with AcariaHealth by following us on LinkedIn. We’re excited to keep you informed about the latest news and updates!